Does adjuvant radiotherapy increase survival in patients with Merkel cell carcinoma of the skin?
Marc Bischof
Correspondence Department of Radio-oncology, University of Heidelberg, Im Neuenheimer Feld 400, D–69120 Heidelberg, Germany
Email marc_bischof@med.uni-heidelberg.de
This article has no abstract so we have provided the first paragraph of the full text.
The aggressive nature of MCC, combined with high recurrence rates, frequent regional lymph-node metastases, and the well-known radiosensitivity of this disease indicate that a therapeutic regimen combining surgical excision and postoperative radiotherapy should be used to improve local control. The optimum treatment regimen for MMC remains unclear, however, as the low worldwide incidence of this disease means that only small, retrospective series have been published.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.